Inventor · disambiguated record
Jean-François Bonfanti
Also filed as: BONFANTI JEAN-FRANCOIS · BONFANTI JEAN-FRANÇOIS
46 granted patents·8 pending applications·154 citations·filing 2004–2024
97Inventor score
Files withJANSSEN PHARMACEUTICALS INC22BONFANTI JEAN-FRANCOIS8JANSSEN SCIENCES IRELAND UNLIMITED CO5TIBOTEC PHARM LTD5JANSSEN R & D IRELAND3
Top patents by PatentIndex Score
54 records- 0195US10919854B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Feb 16, 2021·3 cites·28 claims
- 0295US9944598B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2015·Granted Apr 17, 2018·21 cites·17 claims
- 0395US9556176B2Purine derivatives for the treatment of viral infectionsJANSSEN R&D IRELAND·Filed 2012·Granted Jan 31, 2017·29 cites·4 claims
- 0494US11827602B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Nov 28, 2023·2 cites·11 claims
- 0594US10029984B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2016·Granted Jul 24, 2018·21 cites·5 claims
- 0692US10206902B2Mono- or di-substituted indoles as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2015·Granted Feb 19, 2019·14 cites·9 claims
- 0791US10696632B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2016·Granted Jun 30, 2020·3 cites·13 claims
- 0891US8497270B2Macrocyclic integrase inhibitorsTHURING JOHANNES WILHELMUS J·Filed 2010·Granted Jul 30, 2013·13 cites·15 claims
- 0989US11180450B2Substituted indoline derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Nov 23, 2021·2 cites·3 claims
- 1089US10689340B2Substituted indoline derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2017·Granted Jun 23, 2020·4 cites·8 claims
- 1188US12172959B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2023·Granted Dec 24, 2024·0 cites·27 claims
- 1288US2025230127A1Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1387US9416114B21,2,4-triazine derivatives for the treatment of viral infectionsCENTRE NAT DE LA RECH SCIENT (CNRS)·Filed 2013·Granted Aug 16, 2016·26 cites·7 claims
- 1482US10266543B2Macrocyclic deaza-purinones for the treatment of viral infectionsJANSSEN SCIENCES IRELAND UC·Filed 2014·Granted Apr 23, 2019·2 cites·20 claims
- 1580US11267844B2Spirothietane nucleosidesJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Mar 8, 2022·1 cites·9 claims
- 1676US10280167B2Purine derivatives for the treatment of viral infectionsJANSSEN SCIENCES IRELAND UC·Filed 2017·Granted May 7, 2019·1 cites·4 claims
- 1776US8034835B21-[[2-amino-3-(substituted alkyl)-3H-benzimidazolyl[methyl]-3-substituted-1,3-dihydro-benzoimidazol-2-ones and structural analogsTIBOTEC PHARM LTD·Filed 2006·Granted Oct 11, 2011·3 cites·13 claims
- 1874US11795149B2Substituted indoline derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Oct 24, 2023·0 cites·13 claims
- 1973US9725432B2Pyrimidine derivatives for the treatment of bacterial diseasesJANSSEN R&D IRELAND·Filed 2013·Granted Aug 8, 2017·2 cites·4 claims
- 2073US2022235052A1Purine derivatives for the treatment of viral infectionsJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2021·Application pending·0 cites
- 2172US7449463B2Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replicationTIBOTEC PHARM LTD·Filed 2004·Granted Nov 11, 2008·6 cites·36 claims
- 2270US11702426B2Macrocyclic deaza-purinones for the treatment of viral infectionsJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2020·Granted Jul 18, 2023·0 cites·11 claims
- 2370US11104678B2Purine derivatives for the treatment of viral infectionsJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2019·Granted Aug 31, 2021·0 cites·12 claims
- 2470US10280180B2Macrocyclic purines for the treatment of viral infectionsJANSSEN SCIENCES IRELAND UC·Filed 2013·Granted May 7, 2019·1 cites·8 claims
- 2569US11702387B2Substituted indoline derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Jul 18, 2023·0 cites·14 claims
- 2668US10829494B2Macrocyclic deaza-purinones for the treatment of viral infectionsJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2019·Granted Nov 10, 2020·0 cites·17 claims
- 2765US10822349B2Macrocyclic purines for the treatment of viral infectionsJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2019·Granted Nov 3, 2020·0 cites·9 claims
- 2865US2023002409A1Macrocyclic flu endonuclease inhibitorsJANSSEN BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 2964US11312727B1Macrocyclic flu endonuclease inhibitorsJANSSEN BIOPHARMA INC·Filed 2019·Granted Apr 26, 2022·0 cites·16 claims
- 3062US11407715B2Substituted indoline derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2018·Granted Aug 9, 2022·0 cites·21 claims
- 3160US11053196B2Substituted indoline derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2018·Granted Jul 6, 2021·0 cites·25 claims
- 3259US11083707B2Substituted indoline derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2018·Granted Aug 10, 2021·0 cites·15 claims
- 3356US7355051B2Piperdine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replicationTIBOTEC PHARM LTD·Filed 2004·Granted Apr 8, 2008·0 cites·8 claims
- 3455US2008146613A1Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replicationBONFANTI JEAN-FRANCOIS·Filed 2008·Application pending·0 cites
- 3554US8278455B25- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replicationBONFANTI JEAN-FRANCOIS·Filed 2008·Granted Oct 2, 2012·0 cites·12 claims
- 3653US8883837B2Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replicationBONFANTI JEAN-FRANCOIS·Filed 2008·Granted Nov 11, 2014·0 cites·28 claims
- 3752US10646469B2Substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2017·Granted May 12, 2020·0 cites·7 claims
- 3852US7994173B22-piperazin-1-yl-3H-imidazo[4,5-b]pyridine derivativesJANSSEN PHARMACEUTICA NV·Filed 2008·Granted Aug 9, 2011·0 cites·11 claims
- 3950US10913716B2Substituted indoline derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2017·Granted Feb 9, 2021·0 cites·16 claims
- 4050US2022409583A1Treatment and Prevention of Dengue DiseaseJANSSEN PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4149US2007093502A15- Or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replicationBONFANTI JEAN-FRANCOIS·Filed 2004·Application pending·0 cites
- 4248US10765662B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2016·Granted Sep 8, 2020·0 cites·17 claims
- 4348US10221157B2Pyrimidine derivatives for the treatment of bacterial diseasesJANSSEN R&D IRELAND·Filed 2017·Granted Mar 5, 2019·0 cites·2 claims
- 4446US2009036466A1Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replicationBONFANTI JEAN-FRANCOIS·Filed 2004·Application pending·0 cites
- 4545US11179368B2Substituted indoline derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2018·Granted Nov 23, 2021·0 cites·10 claims
- 4644US10786484B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2016·Granted Sep 29, 2020·0 cites·17 claims
- 4743US8716293B2Macrocyclic integrase inhibitorsTHURING JOHANNES WILHELMUS J·Filed 2011·Granted May 6, 2014·0 cites·17 claims
- 4843US8044073B2Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replicationTIBOTEC PHARM LTD·Filed 2004·Granted Oct 25, 2011·0 cites·29 claims
- 4942US8178694B2Heterocyclylaminoalkyl substituted benzimidazolesBONFANTI JEAN-FRANCOIS·Filed 2006·Granted May 15, 2012·0 cites·15 claims
- 5042US7956196B21,3-dihydro-benzimidazol-2-ylidene amines as inhibitors of respiratory syncytial virus replicationTIBOTEC PHARM LTD·Filed 2006·Granted Jun 7, 2011·0 cites·19 claims
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jean-François Bonfanti files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →